JP2021503468A5 - - Google Patents

Download PDF

Info

Publication number
JP2021503468A5
JP2021503468A5 JP2020527008A JP2020527008A JP2021503468A5 JP 2021503468 A5 JP2021503468 A5 JP 2021503468A5 JP 2020527008 A JP2020527008 A JP 2020527008A JP 2020527008 A JP2020527008 A JP 2020527008A JP 2021503468 A5 JP2021503468 A5 JP 2021503468A5
Authority
JP
Japan
Prior art keywords
composition
cage
geranate
choline
active compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020527008A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021503468A (ja
JP7425726B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/061532 external-priority patent/WO2019099837A1/en
Publication of JP2021503468A publication Critical patent/JP2021503468A/ja
Publication of JP2021503468A5 publication Critical patent/JP2021503468A5/ja
Priority to JP2024006726A priority Critical patent/JP2024045266A/ja
Priority to JP2024006731A priority patent/JP2024045267A/ja
Application granted granted Critical
Publication of JP7425726B2 publication Critical patent/JP7425726B2/ja
Priority to JP2025185437A priority patent/JP2026012396A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020527008A 2017-11-17 2018-11-16 体内送達のためのイオン液体 Active JP7425726B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2024006726A JP2024045266A (ja) 2017-11-17 2024-01-19 体内送達のためのイオン液体
JP2024006731A JP2024045267A (ja) 2017-11-17 2024-01-19 体内送達のためのイオン液体
JP2025185437A JP2026012396A (ja) 2017-11-17 2025-11-04 体内送達のためのイオン液体

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201762588008P 2017-11-17 2017-11-17
US62/588,008 2017-11-17
US201862681866P 2018-06-07 2018-06-07
US201862681856P 2018-06-07 2018-06-07
US201862681852P 2018-06-07 2018-06-07
US201862681861P 2018-06-07 2018-06-07
US62/681,856 2018-06-07
US62/681,866 2018-06-07
US62/681,861 2018-06-07
US62/681,852 2018-06-07
PCT/US2018/061532 WO2019099837A1 (en) 2017-11-17 2018-11-16 Ionic liquids for internal delivery

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2024006731A Division JP2024045267A (ja) 2017-11-17 2024-01-19 体内送達のためのイオン液体
JP2024006726A Division JP2024045266A (ja) 2017-11-17 2024-01-19 体内送達のためのイオン液体

Publications (3)

Publication Number Publication Date
JP2021503468A JP2021503468A (ja) 2021-02-12
JP2021503468A5 true JP2021503468A5 (https=) 2021-12-16
JP7425726B2 JP7425726B2 (ja) 2024-01-31

Family

ID=66540420

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2020527008A Active JP7425726B2 (ja) 2017-11-17 2018-11-16 体内送達のためのイオン液体
JP2024006731A Pending JP2024045267A (ja) 2017-11-17 2024-01-19 体内送達のためのイオン液体
JP2024006726A Pending JP2024045266A (ja) 2017-11-17 2024-01-19 体内送達のためのイオン液体
JP2025185437A Pending JP2026012396A (ja) 2017-11-17 2025-11-04 体内送達のためのイオン液体

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2024006731A Pending JP2024045267A (ja) 2017-11-17 2024-01-19 体内送達のためのイオン液体
JP2024006726A Pending JP2024045266A (ja) 2017-11-17 2024-01-19 体内送達のためのイオン液体
JP2025185437A Pending JP2026012396A (ja) 2017-11-17 2025-11-04 体内送達のためのイオン液体

Country Status (5)

Country Link
US (3) US11446253B2 (https=)
EP (1) EP3709974A4 (https=)
JP (4) JP7425726B2 (https=)
CN (1) CN111918644A (https=)
WO (1) WO2019099837A1 (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020180534A1 (en) 2019-03-01 2020-09-10 President And Fellows Of Harvard College Methods and compositions for protein delivery
KR20220004066A (ko) * 2019-04-03 2022-01-11 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 약물 전달용 이온성 액체
US20230217977A1 (en) * 2019-04-30 2023-07-13 University Of South Florida Dietary choline supplementation to reduce tumor volume and enhance cognitive response during cancer treatment
CN112190540A (zh) * 2019-07-08 2021-01-08 复旦大学 一类鼻腔给药的促渗剂及其应用
CA3158963A1 (en) * 2019-11-22 2021-05-27 Samir Mitragotri Ionic liquids for drug delivery
JP7525094B2 (ja) * 2020-04-03 2024-07-30 森田薬品工業株式会社 イオン液体を用いたbpa製剤およびbpaを構成物質とするイオン液体
US11684594B2 (en) 2020-05-12 2023-06-27 President And Fellows Of Harvard College Antifungal prophylaxis for cornea
CA3191727A1 (en) * 2020-08-14 2022-02-17 Mayo Foundation For Medical Education And Research Methods and materials for tissue ablation
WO2022051304A1 (en) * 2020-09-01 2022-03-10 I2O Therapeutics, Inc. Ionic liquid formulations for treating diabetes
EP4292583A4 (en) * 2021-02-12 2024-12-18 MEDRx Co., Ltd. COMPOSITION WITH IMPROVED ABSORBABILITY OF A POORLY ABSORBABLE MEDICINAL PRODUCT
WO2022202919A1 (ja) * 2021-03-24 2022-09-29 株式会社 メドレックス アジュバント組成物
WO2022265880A1 (en) * 2021-06-16 2022-12-22 President And Fellows Of Harvard College Improved methods and compositions for drug delivery relating to ionic liquids
US20230024537A1 (en) * 2021-07-24 2023-01-26 Board Of Regents, The University Of Texas System Oral Delivery Compositions for Obesity Management
EP4412587A1 (en) 2021-10-08 2024-08-14 President And Fellows Of Harvard College Ionic liquids for drug delivery
AU2022386166A1 (en) 2021-11-10 2024-06-20 I2O Therapeutics, Inc. Ionic liquid compositions
CN114042032B (zh) * 2021-11-11 2024-04-26 武汉瑞佶生物科技有限公司 一种实现核酸皮肤递送的药物制剂及其制备方法和应用
CN116444392B (zh) * 2022-01-06 2024-09-27 中国药科大学 一类多肽蛋白类药物口服吸收促进剂及其制备方法与用途
US20250205339A1 (en) * 2022-03-31 2025-06-26 Medrx Co., Ltd. Formulation having improved absorbability of low-soluble and/or low-membrane-permeable drug
CN114748416A (zh) * 2022-05-23 2022-07-15 中国药科大学 一种肝素类药物口服制剂及其制备方法
WO2024030844A1 (en) * 2022-08-01 2024-02-08 University Of Mississippi Choline carboxylic acid based ionic liquids as antimicrobial agents
WO2024076715A1 (en) * 2022-10-07 2024-04-11 President And Fellows Of Harvard College Methods and compositions relating to improved ionic liquid adjuvants
US12587274B2 (en) 2023-03-28 2026-03-24 Quantum Generative Materials Llc Satellite optimization management system based on natural language input and artificial intelligence
CN116059309B (zh) * 2023-04-06 2023-06-30 江西中医药大学 一种精油组合物及其制备方法
US12603701B2 (en) 2023-12-27 2026-04-14 Quantum Generative Materials Llc Distributed satellite constellation management and control system
US12368503B2 (en) 2023-12-27 2025-07-22 Quantum Generative Materials Llc Intent-based satellite transmit management based on preexisting historical location and machine learning
WO2025184364A1 (en) * 2024-03-01 2025-09-04 University Of Notre Dame Du Lac Self-assembling depots of adjuvant peptide therapies

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124061A (en) 1991-04-01 1992-06-23 Geary Sr Robert J Systemic plant cryoprotection with choline salts
GB0228571D0 (en) 2002-12-06 2003-01-15 Novartis Ag Organic compounds
GB0312309D0 (en) * 2003-05-29 2003-07-02 Gaslini Children S Hospital G Targeted liposome
AU2006302237C1 (en) * 2005-10-07 2012-11-08 The University Of Alabama Multi-functional ionic liquid compositions
WO2012051567A2 (en) * 2010-10-15 2012-04-19 The Trustees Of Columbia University In The City Of New York Obesity-related genes and their proteins and uses thereof
US9216160B2 (en) 2011-10-05 2015-12-22 Jeffrey M. Golini Choline composition
WO2014098869A1 (en) 2012-12-20 2014-06-26 Colgate-Palmolive Company Oral care composition containing ionic liquids
IL312865B2 (en) * 2013-09-11 2025-06-01 Eagle Biologics Inc Liquid protein formulations containing viscosity-lowering agents
WO2015066647A2 (en) 2013-11-03 2015-05-07 The Regents Of The University Of California Ionic liquids for transdermal drug delivery
AU2015325055B2 (en) * 2014-10-01 2021-02-25 Eagle Biologics, Inc. Polysaccharide and nucleic acid formulations containing viscosity-lowering agents
KR101764018B1 (ko) * 2015-11-04 2017-08-16 포항공과대학교 산학협력단 고성능 리튬-황 전지 유-무기 복합 전해질
KR20170052278A (ko) * 2015-11-04 2017-05-12 주식회사 엘지생활건강 바이오필름 제거용 구강 조성물
KR101978828B1 (ko) * 2016-03-21 2019-05-15 주식회사 엘지생활건강 바이오필름 제거용 조성물
WO2017164627A2 (ko) * 2016-03-21 2017-09-28 주식회사 엘지생활건강 바이오필름 억제 또는 제거용 조성물
JP7179354B2 (ja) 2016-08-29 2022-11-29 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 皮膚処置のためのイオン種に基づく局所処方物
US10293080B2 (en) * 2016-10-05 2019-05-21 The Arizona Board Of Regents On Behalf Of Northern Arizona University Ionic liquids that sterilize and prevent biofilm formation in skin wound healing devices
CN106420610B (zh) 2016-10-21 2019-06-11 昆明理工大学 一种离子液体微乳及其应用
CN110087763A (zh) * 2016-11-22 2019-08-02 伊勒卓菲公司 包含治疗剂或诊断剂的颗粒和悬浮液以及其使用方法
US11213497B2 (en) 2017-06-01 2022-01-04 Arizona Board Of Regents On Behalf Of Northern Arizona University Antibiofilm formulations

Similar Documents

Publication Publication Date Title
JP2021503468A5 (https=)
KR950013452B1 (ko) 세포 및 조직 수복제
Mohammadi et al. Bacterial cellulose-based composites as vehicles for dermal and transdermal drug delivery: a review
CN101601646B (zh) 治疗糖尿病的鼻腔滴剂及其制备方法
US20130096048A1 (en) Treatment of sepsis and septic shock using ghrelin and growth hormone
CN115813920A (zh) 1,2,4三唑并4,3-b哒嗪衍生物在制备治疗慢性肾病的药物中的应用
WO2022051304A1 (en) Ionic liquid formulations for treating diabetes
JPS6310728A (ja) ジサツカライド誘導体含有鎮痛剤
JP2025015727A (ja) p-ボロノフェニルアラニンを含有する注射液剤
TW202200143A (zh) 治療
WO2020143744A1 (en) New formulations containing leukotriene receptor antagonists
McKinley Pharmacological Implications of Drug Administration Routes
EP3996679B1 (en) High concentration insulin formulation
JPH0764746B2 (ja) ショック症状を治療するためのacth(1―24)を含有する薬剤組成物
CN116635023A (zh) 用于治疗糖尿病的离子液体制剂
ES2339263T3 (es) Uso de trifluoroacetato de calcio par ala preparacion de medicamentos con efecto antiangiogenico.
GB2421908A (en) Medicament for treatment of inflammatory diseases
JPS60174726A (ja) 注射用医薬組成物
CN117224514B (zh) 一种化合物、组合物及其在制备治疗心律失常的药物中的应用
CN110538191A (zh) 虫草素在制备防治男性性功能障碍相关制剂中的应用
JPH01501708A (ja) アミノ酸の経鼻投与
JPS58164516A (ja) 湿疹性皮膚疾患および薬疹治療剤
RU2655763C2 (ru) Фармацевтическая композиция и способ лечения женских сексуальных дисфункций
Harvey Routes of administration for the non-human primate
CN106692976B (zh) P-糖蛋白抑制剂Gelucire44/14作为经口服的盐酸小檗碱吸收促进剂的应用